sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide

C131H181ClN32NaO31P — CID 158064228

About sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide

sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide (PubChem CID 158064228) has the molecular formula C131H181ClN32NaO31P and a molecular weight of 2789.50 g/mol. Its IUPAC name is sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide.

Molecular Properties

• Compound Name: sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide
• PubChem CID: 158064228
• Molecular Formula: C131H181ClN32NaO31P
• Molecular Weight: 2789.50 g/mol
• Exact Mass: 2787.29
• IUPAC Name: sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide
• SMILES: CCO[C@@H]1[C@H](C)[C@@H](CO)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](C)[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](N)[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(OCc3ccccc3)nc(NC(=O)C(C)C)nc21.COc1ccc(C(Cl)(c2ccccc2)c2ccccc2)cc1.[C-]#[N+]CCOP(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(NC(=O)C(C)C)nc32)[C@H](OCC)[C@@H]1C)N(C(C)C)C(C)C.[NH-]O.[Na+]
• InChI: InChI=1S/C27H34N8O6.C26H42N7O6P.C21H31N5O6.C20H17ClO.C20H30N6O6.C17H25N5O5.H2NO.Na/c1-6-38-21-19(33-34-28)18(13-40-26(37)16(4)5)41-25(21)35-14-29-20-22(35)30-27(31-23(36)15(2)3)32-24(20)39-12-17-10-8-7-9-11-17;1-10-36-21-18(8)19(13-38-40(37-12-11-27-9)33(16(4)5)17(6)7)39-25(21)32-14-28-20-22(32)29-26(31-24(20)35)30-23(34)15(2)3;1-7-30-15-12(6)13(8-31-20(29)11(4)5)32-19(15)26-9-22-14-16(26)23-21(25-18(14)28)24-17(27)10(2)3;1-22-19-14-12-18(13-15-19)20(21,16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-6-30-14-12(21)11(7-31-19(29)10(4)5)32-18(14)26-8-22-13-15(26)23-20(25-17(13)28)24-16(27)9(2)3;1-5-26-12-9(4)10(6-23)27-16(12)22-7-18-11-13(22)19-17(21-15(11)25)20-14(24)8(2)3;1-2;/h7-11,14-16,18-19,21,25H,6,12-13H2,1-5H3,(H,30,31,32,36);14-19,21,25H,10-13H2,1-8H3,(H2,29,30,31,34,35);9-13,15,19H,7-8H2,1-6H3,(H2,23,24,25,27,28);2-15H,1H3;8-12,14,18H,6-7,21H2,1-5H3,(H2,23,24,25,27,28);7-10,12,16,23H,5-6H2,1-4H3,(H2,19,20,21,24,25);1-2H;/q;;;;;;-1;+1/t18-,19-,21-,25-;18-,19-,21-,25-,40?;12-,13-,15-,19-;;11-,12-,14-,18-;9-,10-,12-,16-;;/m111.11../s1
• InChIKey: FLAIYXYNFMDTOI-WNNVFPNRSA-N
• XLogP: 13.83
• TPSA: 798.14 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 50
• Rotatable Bonds: 52
• Heavy Atoms: 197
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2789.50
LogP ≤ 5	13.83
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	50

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Azido_group', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide?

The IUPAC name of sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide (CID 158064228) is sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide.

What is the SMILES notation for sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide?

The canonical SMILES for sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide is CCO[C@@H]1[C@H](C)[C@@H](CO)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](C)[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](N)[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(=O)[nH]c(NC(=O)C(C)C)nc21.CCO[C@@H]1[C@H](N=[N+]=[N-])[C@@H](COC(=O)C(C)C)O[C@H]1n1cnc2c(OCc3ccccc3)nc(NC(=O)C(C)C)nc21.COc1ccc(C(Cl)(c2ccccc2)c2ccccc2)cc1.[C-]#[N+]CCOP(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(NC(=O)C(C)C)nc32)[C@H](OCC)[C@@H]1C)N(C(C)C)C(C)C.[NH-]O.[Na+].

What is the InChIKey of sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide?

The InChIKey is FLAIYXYNFMDTOI-WNNVFPNRSA-N. The full InChI is InChI=1S/C27H34N8O6.C26H42N7O6P.C21H31N5O6.C20H17ClO.C20H30N6O6.C17H25N5O5.H2NO.Na/c1-6-38-21-19(33-34-28)18(13-40-26(37)16(4)5)41-25(21)35-14-29-20-22(35)30-27(31-23(36)15(2)3)32-24(20)39-12-17-10-8-7-9-11-17;1-10-36-21-18(8)19(13-38-40(37-12-11-27-9)33(16(4)5)17(6)7)39-25(21)32-14-28-20-22(32)29-26(31-24(20)35)30-23(34)15(2)3;1-7-30-15-12(6)13(8-31-20(29)11(4)5)32-19(15)26-9-22-14-16(26)23-21(25-18(14)28)24-17(27)10(2)3;1-22-19-14-12-18(13-15-19)20(21,16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-6-30-14-12(21)11(7-31-19(29)10(4)5)32-18(14)26-8-22-13-15(26)23-20(25-17(13)28)24-16(27)9(2)3;1-5-26-12-9(4)10(6-23)27-16(12)22-7-18-11-13(22)19-17(21-15(11)25)20-14(24)8(2)3;1-2;/h7-11,14-16,18-19,21,25H,6,12-13H2,1-5H3,(H,30,31,32,36);14-19,21,25H,10-13H2,1-8H3,(H2,29,30,31,34,35);9-13,15,19H,7-8H2,1-6H3,(H2,23,24,25,27,28);2-15H,1H3;8-12,14,18H,6-7,21H2,1-5H3,(H2,23,24,25,27,28);7-10,12,16,23H,5-6H2,1-4H3,(H2,19,20,21,24,25);1-2H;/q;;;;;;-1;+1/t18-,19-,21-,25-;18-,19-,21-,25-,40?;12-,13-,15-,19-;;11-,12-,14-,18-;9-,10-,12-,16-;;/m111.11../s1.

What are the key properties of sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide?

sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide has a molecular weight of 2789.50 g/mol, XLogP of 13.83, 52 rotatable bonds, 12 hydrogen bond donors, and 50 hydrogen bond acceptors.

Where does this data come from?

All data for sodium;[(2S,3R,4R,5R)-3-amino-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;[(2S,3R,4R,5R)-3-azido-4-ethoxy-5-[2-(2-methylpropanoylamino)-6-phenylmethoxypurin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;1-[chloro(diphenyl)methyl]-4-methoxybenzene;N-[9-[(2R,3R,4R,5S)-5-[[[di(propan-2-yl)amino]-(2-isocyanoethoxy)phosphanyl]oxymethyl]-3-ethoxy-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;N-[9-[(2R,3R,4R,5S)-3-ethoxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide;[(2S,3R,4R,5R)-4-ethoxy-3-methyl-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl 2-methylpropanoate;hydroxyazanide is sourced from PubChem (CID 158064228), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).